Jefferies increases its price target from $4 to $6 on Hold-rated POZEN POZN as the company expects a partnership for PA32540 in 2012.
Jefferies comments, "Reported wider 1Q12 net loss of $8.4M (vs. our net loss estimate of $7.1M) on ~in-line total revenue of $1.3M (vs. our/cons of $1.1M/$1.3M est.) and ~17% higher OpEx. Cash balance of ~$101M at end-1Q12 should be sufficient through 2014 by our estimates. NDA filing
for PA32540 could be potentially delayed by ~6 months although POZN still anticipates a partnership for PA32540 by YE12."
POZN closed at $6.66 on Tuesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in